Immunologic Effects of Supplemental Monosaccharide and Nucleoside Derivatives in Patients With Inherited Disorders of Glycosylation | MicrobiomeTrials← Back to trialsNCT02511041
Immunologic Effects of Supplemental Monosaccharide and Nucleoside Derivatives in Patients With Inherited Disorders of Glycosylation
TERMINATEDPHASE1INTERVENTIONAL
Trial Details
Start: 2015-06-30Est. Completion: 2017-01-24
Enrollment target: 2 participants Locations- National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
PGM3 DeficiencyEosinophilic and/or Atopic DermatitisOSMR DeficiencyPrimary Localized Cutaneous AmyloidosisHereditary Alpha-tryptasemia
Background:
\- Allergic inflammation is central to allergy-related diseases and disorders, such as asthma, food allergi…
Bethesda, United States
InfectionsPneumoniaImmune System DiseasesSTAT3 Transcription FactorJob Syndrome
The Hyper IgE Syndromes (HIES) are primary immunodeficiencies resulting in eczema and recurrent skin and lung infections…